These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29379285)

  • 1. Imaging and kinetics of the bimolecular complex formed by the tumor suppressor p53 with ubiquitin ligase COP1 as studied by atomic force microscopy and surface plasmon resonance.
    Moscetti I; Bizzarri AR; Cannistraro S
    Int J Nanomedicine; 2018; 13():251-259. PubMed ID: 29379285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding kinetics of mutant p53R175H with wild type p53 and p63: A Surface Plasmon Resonance and Atomic Force Spectroscopy study.
    Moscetti I; Bizzarri AR; Cannistraro S
    Biophys Chem; 2017 Sep; 228():55-61. PubMed ID: 28697449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of mutant p53 with p73: a Surface Plasmon Resonance and Atomic Force Spectroscopy study.
    Santini S; Di Agostino S; Coppari E; Bizzarri AR; Blandino G; Cannistraro S
    Biochim Biophys Acta; 2014 Jun; 1840(6):1958-64. PubMed ID: 24576672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2-MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonance.
    Moscetti I; Teveroni E; Moretti F; Bizzarri AR; Cannistraro S
    Int J Nanomedicine; 2016; 11():4221-9. PubMed ID: 27621617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
    Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
    Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Plasmon Resonance Sensing of Biorecognition Interactions within the Tumor Suppressor p53 Network.
    Moscetti I; Cannistraro S; Bizzarri AR
    Sensors (Basel); 2017 Nov; 17(11):. PubMed ID: 29156626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface plasmon resonance imaging protein arrays for analysis of triple protein interactions of HPV, E6, E6AP, and p53.
    Ro HS; Koh BH; Jung SO; Park HK; Shin YB; Kim MG; Chung BH
    Proteomics; 2006 Apr; 6(7):2108-11. PubMed ID: 16493710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 ubiquitination: Mdm2 and beyond.
    Brooks CL; Gu W
    Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies.
    Signorelli S; Santini S; Yamada T; Bizzarri AR; Beattie CW; Cannistraro S
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):910-921. PubMed ID: 28126403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
    Carrero ZI; Kollareddy M; Chauhan KM; Ramakrishnan G; Martinez LA
    Oncotarget; 2016 Mar; 7(11):12554-67. PubMed ID: 26871468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of p53 with Mdm2 and azurin as studied by atomic force spectroscopy.
    Funari G; Domenici F; Nardinocchi L; Puca R; D'Orazi G; Bizzarri AR; Cannistraro S
    J Mol Recognit; 2010; 23(4):343-51. PubMed ID: 19941302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good COP1 or bad COP1? In vivo veritas.
    Wei W; Kaelin WG
    J Clin Invest; 2011 Apr; 121(4):1263-5. PubMed ID: 21403396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.
    Dornan D; Bheddah S; Newton K; Ince W; Frantz GD; Dowd P; Koeppen H; Dixit VM; French DM
    Cancer Res; 2004 Oct; 64(20):7226-30. PubMed ID: 15492238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.
    Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC
    J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the COP1 protein in cancer development and therapy.
    Song Y; Liu Y; Pan S; Xie S; Wang ZW; Zhu X
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):43-52. PubMed ID: 32027978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p53 circuitry in tumorigenesis: A brief review.
    Niazi S; Purohit M; Niazi JH
    Eur J Med Chem; 2018 Oct; 158():7-24. PubMed ID: 30199707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.